|
Characteristics
|
Basic population (cohort A)
|
Respondents (cohort F)
|
Non-participants (cohort D)
|
p-value for difference between cohort F & D
|
|---|
| |
%
|
%
|
%
| |
|---|
|
Melanoma
| | | | |
|
N
|
1,503
|
608
|
895
| |
|
Sex
| | | |
0.093
|
|
Male
|
43.4
|
46.1
|
41.7
| |
|
Female
|
56.6
|
53.9
|
58.3
| |
|
Surgery
| | | |
0.877
|
|
Yes
|
87.9
|
88.3
|
87.6
| |
|
No
|
0.4
|
0.3
|
0.4
| |
|
Unknown
|
11.7
|
11.3
|
12.0
| |
|
T-category
| | | |
0.208
|
|
T1
|
30.9
|
30.9
|
30.8
| |
|
T2
|
11.8
|
10.7
|
12.5
| |
|
T3
|
8.4
|
9.0
|
8.0
| |
|
T4
|
2.7
|
1.6
|
3.4
| |
|
Unknown
|
46.2
|
47.7
|
45.3
| |
|
Spatial category
| | | |
0.261
|
|
Rural
|
46.6
|
48.4
|
45.4
| |
|
Urban
|
53.4
|
51.6
|
54.6
| |
| |
(N = 1,500)
| |
(N = 892)
| |
|
Breast cancer
| | | | |
|
N
|
5,248
|
1,927
|
3,321
| |
|
Surgery
| | | |
< 0.001
|
|
Yes
|
88.8
|
93.2
|
86.3
| |
|
No
|
1.9
|
0.5
|
2.8
| |
|
Unknown
|
9.2
|
6.3
|
10.9
| |
|
T-category
| | | |
< 0.001
|
|
T1
|
48.4
|
53.8
|
45.3
| |
|
T2
|
34.4
|
34.6
|
34.3
| |
|
T3
|
4.8
|
4.5
|
5.0
| |
|
T4
|
6.9
|
3.4
|
9.0
| |
|
Unknown
|
5.4
|
3.7
|
6.4
| |
|
Spatial category
| | | |
< 0.001
|
|
Rural
|
52.1
|
48.6
|
54.2
| |
|
Urban
|
47.9
|
51.4
|
45.8
| |
| |
(N = 5,228)
| |
(N = 3,301)
| |
|
Prostate cancer
| | | | |
|
N
|
4,738
|
1,750
|
2,988
| |
|
Surgery
| | | |
< 0.001
|
|
Yes
|
46.3
|
56.4
|
40.5
| |
|
No
|
19.8
|
17.6
|
21.0
| |
|
Unknown
|
33.9
|
26.0
|
38.5
| |
|
Hormone therapy
| | |
< 0.001
| |
|
Yes
|
31.5
|
28.2
|
33.4
| |
|
No
|
28.2
|
34.3
|
24.6
| |
|
Unknown
|
40.3
|
37.4
|
42.0
| |
|
T-category
| | | |
< 0.001
|
|
T1
|
15.9
|
15.0
|
16.4
| |
|
T2
|
39.0
|
45.8
|
35.0
| |
|
T3
|
22.8
|
28.5
|
19.5
| |
|
T4
|
1.9
|
1.5
|
2.2
| |
|
Unknown
|
20.4
|
9.3
|
27.0
| |
|
Spatial category
| | | |
0.124
|
|
Rural
|
54.8
|
56.3
|
54.0
| |
|
Urban
|
45.2
|
43.7
|
46.0
| |
| |
(N = 4,718)
| |
(N = 2,968)
| |
